Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Glucose Health, Inc. (GLUC : OTC)

• Company Description    Glucose Health, Inc. is involved in manufacturing dietary supplements for Type 2 diabetes. The company's principal product is Glucose Health natural blood sugar maintenance product. Glucose Health, Inc. is based in Bentonville, Arkansas. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $0.10 Daily Weekly Monthly 20 Day Moving Average: 6,117 shares Shares Outstanding: 17.41 (millions) Market Capitalization: $1.71 (millions) Beta: 1.87 52 Week High: $0.44 52 Week Low: $0.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.72% -3.05% 12 Week 8.88% -8.42% Year To Date -18.25% -23.44%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 609 SW 8TH STREET 6TH FLOOR - BENTONVILLE,AR 72712 USA ph: 479-802-3827 fax: - info@glucosehealthinc.com http://www.glucosehealthinc.com

• General Corporate Information    Officers Murray Fleming - Chief Executive Officer Hal Kravitz - Director Gerry David - Director Peggy Knight - Executive Vice President William Gallagher - Director Peer Information Glucose Health, Inc. (BJCT) Glucose Health, Inc. (CADMQ) Glucose Health, Inc. (APNO) Glucose Health, Inc. (UPDC) Glucose Health, Inc. (IMTIQ) Glucose Health, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 379894108 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/24 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 17.41 Most Recent Split Date: (:1) Beta: 1.87 Market Capitalization: $1.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 4.45 EPS Growth vs. Year Ago Period: 100.00% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: -40.78% vs. Previous Quarter: -11.59% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - - Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -82.29 Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - -82.29 Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©